Related Experiment Video
Updated: May 4, 2026

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
Cardiac magnetic resonance in acute myocardial infarction undergoing thrombus aspiration
Alberico Del Torto1, Ettore Ventura1, Francesco Cannata1
1Department of Perioperative Cardiology and Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS, Milan, Italy.
Background:
Microvascular obstruction (MVO) is a major prognostic determinant in STEMI. While thrombus aspiration (TA) during primary percutaneous coronary intervention (PCI) aims to reduce distal embolization and MVO, its impact on long-term myocardial scar and remodeling remains debated. The present study aimed to evaluate the impact of clinically indicated TA on myocardial scar and MVO using cardiac magnetic resonance (CMR) at baseline and 12-month follow-up in STEMI patients treated with PCI.
Methods:
In this single-center observational cohort study, consecutive STEMI patients treated with primary PCI ± TA who underwent CMR at baseline and at 12 months were enrolled. CMR parameters included left ventricular volumes, ejection fraction, global longitudinal strain, infarct size (late gadolinium enhancement) and MVO.
Results:
Among 130 STEMI patients (84 PCI + TA, 46 PCI-alone) enrolled, the TA group had higher baseline thrombus burden (TIMI Thrombus Grade 5 [5;5] vs. 3 (Henriques et al., 2002; Byrne et al., 2023 [2, 5]), p < 0.001), higher MVO prevalence (44.6% vs. 25%, p = 0.03) and larger infarct size [late gadolinium enhancement LGE: 24.2% vs 17.5% of left ventricle (LV) myocardial mass, p = 0.001]. At follow-up CMR, PCI + TA group experienced a greater reduction in myocardial scar (-5.0% [-21.8; 1.4] vs. -3.28% [-17.9; 4.6], p < 0.05), particularly in patients with a high thrombus burden (Thrombus Grade > 3) and baseline MVO (-10.3% [-19.8; -2.5] vs. -3.7% [-9.5; 1.2], p < 0.05).
Conclusions:
Despite worse baseline clinical and imaging characteristics, STEMI patients treated with TA showed more favorable myocardial tissue recovery at 12 months. These findings suggest that TA may optimize conditions for scar consolidation, particularly in high-risk patients with heavy thrombus burden.
Insights
Thrombus aspiration during primary PCI in STEMI patients improved myocardial scar recovery at 12 months, especially in those with high thrombus burden and microvascular obstruction.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiovascular Imaging
Background:
- Microvascular obstruction (MVO) is a key prognostic factor in ST-elevation myocardial infarction (STEMI).
- Thrombus aspiration (TA) during primary percutaneous coronary intervention (PCI) aims to reduce MVO, but its long-term effects on myocardial scar are debated.
Purpose of the Study:
- To evaluate the impact of clinically indicated TA on myocardial scar and MVO.
- Assess long-term myocardial remodeling using cardiac magnetic resonance (CMR) at 12-month follow-up in STEMI patients treated with PCI.
Main Methods:
- Single-center observational cohort study of STEMI patients undergoing primary PCI ± TA.
- Cardiac magnetic resonance (CMR) imaging at baseline and 12 months to assess LV volumes, ejection fraction, global longitudinal strain, infarct size (LGE), and MVO.
Main Results:
- The PCI + TA group (n=84) had higher baseline thrombus burden, MVO prevalence, and infarct size compared to PCI-alone (n=46).
- At 12 months, the PCI + TA group showed a greater reduction in myocardial scar.
- This scar reduction was more pronounced in patients with high baseline thrombus burden and MVO.
Conclusions:
- STEMI patients treated with TA demonstrated improved myocardial tissue recovery at 12 months, despite worse baseline characteristics.
- TA may promote favorable scar consolidation, particularly in high-risk patients with significant thrombus burden.
More Related Videos
09:59A Magnetic Resonance Imaging Protocol for Stroke Onset Time Estimation in Permanent Cerebral Ischemia
Published on: September 16, 2017
12:24Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Related Concept Videos
Imaging Studies for Cardiovascular System IV: CMRI
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System V: CT
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Magnetic Resonance Imaging